A novel antigen-carrier system: The Mycobacterium tuberculosis Acr protein carried by raw starch microparticles

International Journal of Pharmaceutics

Volumn 474, Issue 1-2, 2014, Pages 241-248

  Moreno Mendieta, S A ^a   Guillen D ^a   Espitia, C ^a   Hernandez Pando R ^b   Sanchez, S ^a   Rodriguez Sanoja R ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Binding; Domain tag; Microparticle vaccines; Mucosal immunization; Protein delivery; Starch; Starch microparticles

Indexed keywords

ADJUVANT; ALPHA CRYSTALLIN; ANTIGEN; CYTOKINE; DRUG CARRIER; GAMMA INTERFERON; HEAT SHOCK PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; POLYMER; RECOMBINANT PROTEIN; STARCH; STARCH BINDING DOMAIN TAG; STARCH MICROPARTICLE; SUBUNIT VACCINE; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; HSPX PROTEIN, MYCOBACTERIUM TUBERCULOSIS; MICROSPHERE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN DELIVERY; PROTEIN DOMAIN; PROTEIN IMMOBILIZATION; RESPIRATORY SYSTEM; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMISTRY; FEMALE; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METABOLISM; MUCOSAL IMMUNITY; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; VACCINATION;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTIGENS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DRUG CARRIERS; FEMALE; IMMUNITY, MUCOSAL; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; MICROSPHERES; PARTICLE SIZE; STARCH; VACCINATION; VACCINES, SUBUNIT;

EID: 84910046185     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.07.041     Document Type: Article

References (41)

1. M. Amidi N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model Vaccine 25 2007 144 153
2. R. Audran Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro Vaccine 21 2003 1250 1255
3. E. Balasse Enhanced immune response induced by BSA loaded in hydroxyethylstarch microparticles Int. J. Pharm. 353 2008 131 138
4. D. Coucke Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine Vaccine 27 2009 1279 1286
5. N. Csaba Nanoparticles for nasal vaccination Adv. Drug. Del. Rev. 61 2008 140 157
6. A. Demissie Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis Clin. Vacc. Immunol. 13 2006 179 186
7. P. Elamanchili Characterisation of poly(d,l-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells Vaccine 22 2004 2406 2412
8. P. Elamanchili Pathogen-mimicking nanoparticles for vaccine delivery to dendritic cells J. Immunother. 30 2007 378 395
9. J.E. Eyles Immunological aspects of polymer microsphere vaccine delivery systems J. Drug Target. 11 2003 509 514
10. D. Guillén The starch-binding domain as a tool for recombinant protein purification Appl. Microbiol. Biotechnol. 97 2013 4141 4148
11. I. Gutierro Influence of dose and inmunization route on the serum IgG antibody response to BSA loaded PLGA microspheres Vaccine 20 2002 2181 2190
12. P.L. Heritage Novel polymer grafted starch microparticles for mucosal delivery of vaccines Immunlogy 88 1996 162 168
13. J. Kunisawa Immunological commonalities and distinctions between airway and digestive immunity Trends Immunol. 29 2008 505 513
14. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
15. P. Malyala Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles Adv. Drug Del. Rev. 61 2009 218 225
16. I.M. Monahan Differential expression of mycobacterial proteins following phagocytosis by macrophages Microbiology 147 2001 459 471
17. Moreno-Mendieta, S.A., et al., 2014. Gastrointestinal stability of proteins immobilized on raw starch microparticles. (submitted for publication).
18. J. Nilsson Affinity fusion strategies for detection purification, and immobilization of recombinant proteins Protein Expres. Pur. 11 1997 1 16
19. H. Niu Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb 10.4-HspX Vaccine 29 2011 9451 9458
20. D.T. O'Hagan Microparticles and polymers for the mucosal delivery of vaccines Adv. Drug Deliv. Rev. 34 1998 305 320
21. D.T. O'Hagan, and N.M. Valiante Recent advances in the discovery and delivery of vaccine adjuvants Nat. Rev. Drug Discov. 2 2003 727 735
22. I. Pepponi 2013. Immune-complex mimics as a molecular platform for adjuvant-free vaccine delivery PLoS One 8 2013 e60855 10.1371/journal.pone.0060855
23. Y. Perrie Vaccine adjuvant systems enhancing the efficacy of sub-unit protein antigens Int. J. Pharm. 364 2008 272 280
24. N. Petrovsky, and P.D. Cooper Carbohydrate-based immune adjuvants Expert Rev. Vaccines 10 2011 523 537
25. S.T. Reddy Targeting dendritic cells with biomaterials: developing the next generation of vaccines Trends Immunol. 27 2006 574 579
26. I. Rosenkrands Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins J. Bacteriol. 184 2002 3485 3491
27. V. Roupie Immunogenecity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice Infect. Immun. 75 2007 941 949
28. N. Rydell, and I. Sjöholm Mucosal vaccination against diphtheria using starch microparticles as adjuvant for cross-reacting material (CRM197) of diphtheria toxin Vaccine 23 2005 2775 2783
29. J. Sambrook Molecular Cloning: A Laboratory Manual 1989 Cold Spring Harbor Laboratory Cold Spring Harbor, NY 1626
30. S. Singh Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis Vaccine 2013 10.1016/j.vaccine.2013.11.065
31. L. Stertman Starch microparticles as an adjuvant in immunisation: effect of route of administration on the immune response in mice Vaccine 22 2004 2863 2872
32. J. Todoroff Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice PLoS One 8 2013 e63344 10.1371/journal.pone.0063344
33. M. van de Weert Protein instability in poly (lactic-co-glycolic acid) microparticles Pharm. Res. 17 2000 1159 1167
34. M. Vajdy, and D.T. O'Hagan Microparticles for intranasal inmunization Adv. Drug Deliv. Rev. 51 2001 127 141
35. J.A. Villadangos, and P. Schnorrer Intrinsic and cooperative antigen presenting functions of dendritic-cell subsets in vivo Nature Rev. Immunol. 7 2007 543 555
36. Y. Waeckerle-Men, and M. Groettrup PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines Adv. Drug Deliv. Rev. 10 2005 475 482
37. H.L. Weiner Oral tolerance Immunol. Rev. 241 2011 241 259
38. L.D. Wikingsson, and I. Sjöholm Polyacryl starch microparticles as adjuvant in oral immunisation inducing mucosal and systemic immune responses in mice Vaccine 20 2002 3355 3363
39. Y. Yuan The 16-kDa a-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages PNAS 95 1998 9578 9583
40. L. Zhao Nanoparticle vaccines Vaccine 32 2014 327 337
41. A. Zvi Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bionformatic analyses BMC Med. Genom. 1 2008 18 10.1186/1755-8794-1-18